当地时间3月18日，诺和诺德基金会宣布，将与全球领先的图形处理单元（GPU）制造商英伟达合作，在丹麦打造一台名为Gefion的超级计算机。该计算机将采用英伟达先进的AI技术，旨在加速新药的发现和治疗方法的研发。这台超级计算机不仅将服务于诺和诺德背后的企业基金会，还将向丹麦公共和私营部门的研究人员开放。
英伟达以其高性能计算和图形处理能力而闻名，这些技术对于模拟和分析复杂的生物数据至关重要。通过这次合作，诺和诺德基金会旨在利用英伟达的技术优势，推动药物开发领域的创新。Gefion超级计算机的建立，预计将大大缩短新药从实验室到市场的周期，为全球健康问题提供更快更有效的解决方案。
随着AI技术的不断进步，药物研发领域正经历着前所未有的变革。通过深度学习和大数据分析，科学家们能够更高效地筛选潜在的药物分子，预测药物的分子活性，甚至在分子水平上模拟药物与生物体的相互作用。这些技术的应用有望降低研发成本，提高研发效率，为人类健康带来革命性的进步。
Gefion超级计算机的建设是诺和诺德基金会和英伟达在推动全球健康和医疗科技发展方面的一次重要合作。这次合作不仅将提升丹麦在药物研发领域的国际竞争力，也将为全球的医疗研究提供强大的技术支持。
英文标题：Novo Nordisk Foundation and NVIDIA Partner to Build AI Supercomputer for Drug and Therapy Discovery
英文关键词：AI Supercomputer, Drug Discovery, Novo Nordisk Foundation, NVIDIA
英文新闻内容：
On March 18, the Novo Nordisk Foundation announced a collaboration with NVIDIA, a global leader in GPU manufacturing, to construct a supercomputer named Gefion in Denmark. The supercomputer will leverage NVIDIA’s advanced AI technology to accelerate the discovery of new drugs and the development of treatments. This supercomputer will not only serve the foundation behind Novo Nordisk but will also be accessible to researchers in both the public and private sectors in Denmark.
NVIDIA is renowned for its high-performance computing and graphics processing capabilities, which are crucial for simulating and analyzing complex biological data. Through this collaboration, the Novo Nordisk Foundation aims to harness NVIDIA’s technological expertise to drive innovation in the field of drug development. The establishment of the Gefion supercomputer is expected to significantly shorten the time it takes for new drugs to move from the laboratory to the market, providing faster and more effective solutions to global health issues.
With the continuous advancement of AI technology, the field of drug development is undergoing unprecedented changes. The application of deep learning and big data analytics enables scientists to efficiently screen potential drug molecules, predict the molecular activity of drugs, and even simulate at the molecular level the interaction between drugs and biological organisms. These technologies promise to lower the cost of research and development, improve efficiency, and bring revolutionary progress to human health.
The construction of the Gefion supercomputer marks an important collaboration between the Novo Nordisk Foundation and NVIDIA in promoting global health and medical technology development. This collaboration is not only expected to enhance Denmark’s international competitiveness in drug development but will also provide powerful technical support for medical research worldwide.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 0